Live News EQUITY FLASH L impact Nov 19, 2026, 12:58 PM UTC GE Healthcare Phase 2 Results Support Mangaciclanol's Advancement to Phase 3 Phase 2 results support advancing mangaciclanol into Phase 3 of the LUMINA trial. GEHC SquawkNews Desk